Details

Contributors. <p>Acknowledgement to Cochrane Library.</p> <p><b>1 Practising evidence-based respiratory medicine.</b></p> <p>1.1 Introduction.</p> <p>1.2 Diagnostic strategies.</p> <p>1.2.1 Presenting symptoms.</p> <p>1.2.2 Lung function testing.</p> <p>1.2.3 Chest radiographic and CT patterns.</p> <p>1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach.</p> <p>1.2.5 Screening for lung cancer.</p> <p>1.3 Therapeutics: general issues.</p> <p>1.3.1 Adherence and self-management.</p> <p>1.3.2 Corticosteroid-induced osteoporosis.</p> <p>1.3.3 Helping people to stop smoking.</p> <p><b>2 Asthma.</b></p> <p>2.1 Acute exacerbations.</p> <p>2.2 Chronic therapy: beta-agonists – short-acting, long-acting beta2-agonists.</p> <p>2.3 Inhaled corticosteroids in the treatment of asthma.</p> <p>2.4 Anti-leukotrienes.</p> <p>2.5 Asthma education.</p> <p>.2.6 Non-pharmacological and complementary interventions to manage asthma.</p> <p>2.7 Difficult asthma.</p> <p>2.8 Novel therapies in asthma: long-acting beta2-agonists/inhaled corticosteroids.</p> <p><b>3 Chronic obstructive pulmonary disease.</b></p> <p>3.1 Chronic obstructive pulmonary disease – acute exacerbations.</p> <p>3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy.</p> <p>3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease.</p> <p>3.4 Combination of inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease.</p> <p>3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease.</p> <p>3.6 Lung volume reduction.</p> <p><b>4 Infection.</b></p> <p>4.1 Bronchitis and sinusitis.</p> <p>4.2 Community-acquired pneumonia.</p> <p>4.3 Pulmonary tuberculosis.</p> <p>4.4 Influenza: vaccination and treatment.</p> <p>4.5 Bronchiectasis.</p> <p>4.6 Adult cystic fibrosis.</p> <p>4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis.</p> <p><b>5 Respiratory failure/sleep disordered breathing.</b></p> <p>5.1 Respiratory rehabilitation.</p> <p>5.2 Non-invasive ventilation in acute respiratory failure.</p> <p>5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?</p> <p>5.4 The treatment of the obstructive sleep apnoea–hypopnoea syndrome.</p> <p>5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease.</p> <p><b>6 Diffuse lung disease / pleural disease / thromboembolism.</b></p> <p>6.1 Diffuse lung disease.</p> <p>6.1.1 The treatment of cryptogenic fibrosing alveolitis.</p> <p>6.1.2 Evidence-based approach to treatment of sarcoidosis.</p> <p>6.1.3 Hypersensitivity pneumonitis.</p> <p>6.2 Pleural disease.</p> <p>6.3 Therapy of pulmonary thromboembolism: an evidence-based approach.</p> <p>6.4 Pulmonary hypertension.</p> <p>Index.</p>

<b>Peter Gibson</b>, Respiratory Medicine Unit, John Hunter Hospital

Compiled by specialists from the Cochrane Collaboration Airways Management Group, <i>Evidence-based Respiratory Medicine</i> is the first major evidence-based text in adult respiratory medicine. <p>Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world's leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter.</p> <p><i>Evidence-based Respiratory Medicine</i> tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient's needs.</p> <p><b>Evidence-Based Series:</b> <i>Evidence-based Respiratory Medicine,</i> part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text.</p>

GB